United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jul 9, 2026 · Filed Jul 9, 2026

On Jul 9, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$551.13 for US$5.24M under a trading plan, leaving 40,513 shares. Filed Jul 9, 2026 (Form 4).

Sold
9,500 shares
Price
US$551.13 average (US$548.16 to US$555.76)
Value
US$5.24M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 9, 2026Common StockOption exercise9,500US$135.4250,013Direct
Jul 9, 2026Common StockSale440US$548.1649,573Direct
Jul 9, 2026Common StockSale1,536US$549.0148,037Direct
Jul 9, 2026Common StockSale1,452US$550.1246,585Direct
Jul 9, 2026Common StockSale2,863US$551.0343,722Direct
Jul 9, 2026Common StockSale1,648US$552.3842,074Direct
Jul 9, 2026Common StockSale801US$553.2941,273Direct
Jul 9, 2026Common StockSale640US$554.2340,633Direct
Jul 9, 2026Common StockSale120US$555.7640,513Direct

Source

View original at SEC

Related